营养与肝再生

doi:10.3969/j.issn.1672-5069.2017.05.004

Abstract

Ji Jing，Li Rongshan，Ren Feng，et al.. Impact of nutrition on liver regeneration[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 523-526.

[1] Fontburgada J，Shalapour S，Ramaswamy S，et al. Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer. Cell，2015，162（4）:766.
[2] Cheung K，Lee SS，Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease，and nutrition management strategies. Clin Gastroenterol Hepatol，2012，10（2）:117.
[3] Bemeur C，Desjardins P，Butterworth RF. Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure. Nutr Metab，2010，2010:489823.
[4] Hiroyuki K，Zhang RR，Yasuharu U，et al. Nutritional modulation of mouse and human liver bud growth through a branched-amino acid metabolism. Development，2017，[ahead of print].
[5] Bukowiecki R， Adjaye J， Prigione A. Mitochondrial function in pluripotent stem cells and cellular reprogramming. Gerontology，2014，60（2）:174-182.
[6] Rondanelli M，Opizzi A，Antoniello N，et al. Effect of essential amino acid supplementation on quality of life，amino acid profile and strength in institutionalized elderly patients. Clin Nutrit，2011，30（5）:571-577.
[7] Kim SJ，Kim DG，Lee MD. Effects of branched-chain amino acid infusions on liver regeneration and plasma amino acid patterns in partially hepatectomized rats. Hepatogastroenterology，2011，58（109）:1280.
[8] Holecek M. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition，2010，26（5）:482-490.
[9] Toshiro M，Ken S，Shohei Y，et al. Nutrition support and infections associated with hepatic resection and liver transplantation in patients with chronic liver disease. JPEN，2013，37（3）:318-326.
[10] Alexander W，Eric H，Vered G，et al. p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology，2009，50（1）:207-215.
[11] Valdecantos MP，Pardo V，Ruiz L，et al. A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice. Hepatology，2017，65（3）:950.
[12] Chen H，Lin Y，Sun W，et al. Liver regeneration is impaired in mice with acute exposure to a very low carbohydrate diet. Digest Dis Sci，2017，62（5）:1256-1264.
[13] Margonis GA，Amini N，Buettner S，et al. Impact of perioperative phosphorus and glucose levels on liver regeneration and long-term outcomes after major liver resection. J Gastrointest Surg，2016，20（7）:1305-1316.
[14] Hassanain M，Schricker T，Metrakos P，et al. Hepatic protection by perioperative metabolic support.Nutrition，2008，24（11）:1217-1219.
[15] Yang SQ，Lin HZ，Mandal AK，et al. Disrupted signaling and inhibited regeneration in obese mice with fatty livers:implications for nonalcoholic fatty liver disease pathophysiology. Hepatology，2001，34（1）:694-706.
[16] Stauffer JK，Scarzello AJ，Jiang Q，et al. Chronic inflammation，immune escape，and oncogenesis in the liver:A unique neighborhood for novel intersections. Hepatology，2012，56（4）:1567. [17] Truant S，Bouras AF，Petrovai G，et al. Volumetric gain of the liver after major hepatectomy in obese patients:a case-matched study in 84 patients. Ann Surg，2013，258（5）:702-704.
[18] Hamano M，Ezaki H，Kiso S，et al. Lipid overloading during liver regeneration causes delayed hepatocyte DNA replication by increasing ER stress in mice with simple hepatic steatosis. J Gastroenterol，2014，49（2）:305-316.
[19] Inaba Y，Furutani T，Kimura K，et al. Growth arrest and DNA damage-inducible 34 regulates liver regeneration in hepatic steatosis in mice. Hepatology，2015，61（4）:1343-1356.
[20] Jahn D，Rau M，Hermanns HM，et al. Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease. Cytok Growth Factor Rev，2015，26（6）:625-635.
[21] Hoppe S，Von LC，Lock JF，et al. Nonalcoholic steatohepatits and liver steatosis modify partial hepatectomy recovery. J Investigat Surg，2015， 28（1）:24.
[22] Alvarezsola G，Uriarte I，Latasa MU，et al. Fibroblast growth factor 15/19（FGF15/19） protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration. Gut，2017，[ahead of print].
[23] Venu M，Martin E，Saeian K，et al. High prevalence of vitamin A and D deficiency in patients evaluated for liver transplantation. Liver Transplant，2013，19（6）:627.
[24] Bitetto D，Bortolotti N，Falleti E，et al. Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy. Hepatology，2013， 57（3）:925-933.
[25] Chantal B，Butterworth RF. Nutrition in the management of cirrhosis and its neurological complications. J Clin Exp Hepatol，2015， 5（1）:131-140.
[26] Carlett H，Ramírez-Farías S，Eduardo A，et al. Protective effect of some vitamins against the toxic action of ethanol on liver regeneration induced by partial hepatectomy in rats. World J Gastroenterol，2008，14（6）:899-907.
[27] Lin M，Sun P，Zhang G，et al. Vitamin K2-enhanced liver regeneration is associated with oval cell expansion and up-regulation of matrilin-2 expression in 2-AAF/PH rat model. Curr Mol Med，2014，14（3）:361.
[28] Laarschot LF，Jansen PLM，Schaap FG，et al. The role of bile salts in liver regeneration. Hepatol Int，2016，10（5）:1-8.
[29] Liu H X，Keane R，Sheng L，et al. Implications of microbiota and bile acid in liver injury and regeneration. J Hepatol，2015，63（6）:1502-1510.

Impact of nutrition on liver regeneration

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	Ren Yufei, Chen Xiaoqing, Kong Weizong, et al.. Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro [J]. Journal of Practical Hepatology, 2019, 22(6): 804-807.
[3]	Li Yingyi, Guo Cuifen, Zhang Ruinan, et al.. Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 848-851.
[4]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[5]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[6]	. [J]. Journal of Practical Hepatology, 2019, 22(5): 624-635.
[7]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[8]	Zhang Lanhua, Shao Qin, Xia Zhenjuan. Changes of serum 25-(OH) D3 and IL-17 levels are associated with progress of nonalcoholic fatty liver disease in obese children [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 522-525.
[9]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[10]	Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.
[11]	Fu Liang, Wu Dongbing, Ji Xinzun. Application of ARFI quantification in the evaluation of liver injuries in patients with non-alcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 377-380.
[12]	Wang Haifang, Yang Dawei, Jia Bei. Impact of nutrition support and medusa administration on liver function, erythrocyte and platelet parameters in patients with alcoholic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 381-384.
[13]	Zhang Tingting, Wang Xuan. Clinical implications of oral glucose tolerance test in cirrhotic patients with hepatogenous diabetes [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 449-452.
[14]	Zhu Guangxi，Wen Liangzhi，Chen Dongfeng. Pathogenesis of non-alcoholic fatty liver disease-related hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 453-456.
[15]	Huo Huiqin, Gong Xiaohong, Li Zhenghong. Assessment of right atrial and ventricular functions in patients with nonalcoholic fatty liver disease-induced liver cirrhosis by real-time three-dimensional echocardiography and speckle tracking imaging [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 244-247.